{"DataElement":{"publicId":"6035033","version":"1","preferredName":"Prostate Cancer Treatment or Active Surveillance Preference Code","preferredDefinition":"Text abbreviation for the preference of treatment or active surveillance for prostate cancer.","longName":"PCA_TX_AS_PREF_CD","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"6034890","version":"1","preferredName":"Prostate Carcinoma Therapeutic Procedure Or Patient Observation Preference","preferredDefinition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002_An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Closely watching a patient's condition but not giving treatment unless there are changes in test results. Active surveillance avoids problems that may be caused by treatments such as radiation or surgery. It is used to find early signs that the condition is getting worse. During active surveillance, patients will be given certain exams and tests done on a regular schedule. It is sometimes used in prostate cancer._The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","longName":"6034888v1.0:6035038v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"6034888","version":"1","preferredName":"Prostate Carcinoma Therapeutic Procedure","preferredDefinition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","longName":"C4863:C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Carcinoma","conceptCode":"C4863","definition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F25D778-9B4B-7DB0-E053-F662850A1255","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6035038","version":"1","preferredName":"Or Patient Observation Preference","preferredDefinition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Closely watching a patient's condition but not giving treatment unless there are changes in test results. Active surveillance avoids problems that may be caused by treatments such as radiation or surgery. It is used to find early signs that the condition is getting worse. During active surveillance, patients will be given certain exams and tests done on a regular schedule. It is sometimes used in prostate cancer.:The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","longName":"C37998:C15722:C41187","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Patient Observation","conceptCode":"C15722","definition":"Closely watching a patient's condition but not giving treatment unless there are changes in test results. Active surveillance avoids problems that may be caused by treatments such as radiation or surgery. It is used to find early signs that the condition is getting worse. During active surveillance, patients will be given certain exams and tests done on a regular schedule. It is sometimes used in prostate cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preference","conceptCode":"C41187","definition":"The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F33EFA9-B3A7-7201-E053-F662850A8D50","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"ONEDATA","dateModified":"2017-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F25D778-9B59-7DB0-E053-F662850A1255","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-29","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeDescription":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6034919","version":"1","preferredName":"Prostate Cancer Treatment Preference Code","preferredDefinition":"A symbol or combination of symbols which is assigned to the members of a collection.","longName":"PCA_TX_PREF_CD","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"NA","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5682946","version":"1","preferredName":"Not Applicable","longName":"5682946v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9B2B-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":"2023.8.15 Alt VM added per ticket request CADSR0002731. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F27EEFA-4075-2FF7-E053-F662850A3F82","beginDate":"2017-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","deletedIndicator":"No"},{"value":"NoPref","valueDescription":"No Preference","ValueMeaning":{"publicId":"6034920","version":"1","preferredName":"No Preference","longName":"6034920","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preference","conceptCode":"C41187","definition":"The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F27EEFA-4082-2FF7-E053-F662850A3F82","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F27EEFA-409B-2FF7-E053-F662850A3F82","beginDate":"2017-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","deletedIndicator":"No"},{"value":"Tx","valueDescription":"Therapeutic Procedure","ValueMeaning":{"publicId":"4726231","version":"1","preferredName":"Therapeutic Procedure","longName":"4726231","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1013AB9C-32D4-698C-E050-BB89AD43129F","latestVersionIndicator":"Yes","beginDate":"2015-02-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2015-02-27","modifiedBy":"GDEEN","dateModified":"2023-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F27EEFA-40AF-2FF7-E053-F662850A3F82","beginDate":"2017-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","deletedIndicator":"No"},{"value":"AS","valueDescription":"Active Surveillance","ValueMeaning":{"publicId":"6034921","version":"1","preferredName":"Active Surveillance","longName":"6034921","preferredDefinition":"Closely watching a patient's condition but not giving treatment unless there are changes in test results. Active surveillance avoids problems that may be caused by treatments such as radiation or surgery. It is used to find early signs that the condition is getting worse. During active surveillance, patients will be given certain exams and tests done on a regular schedule. It is sometimes used in prostate cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient Observation","conceptCode":"C15722","definition":"Closely watching a patient's condition but not giving treatment unless there are changes in test results. Active surveillance avoids problems that may be caused by treatments such as radiation or surgery. It is used to find early signs that the condition is getting worse. During active surveillance, patients will be given certain exams and tests done on a regular schedule. It is sometimes used in prostate cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F27EEFA-40BA-2FF7-E053-F662850A3F82","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F27EEFA-40D3-2FF7-E053-F662850A3F82","beginDate":"2017-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261841","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-6427-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-13","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F27EEFA-4056-2FF7-E053-F662850A3F82","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-29","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeDescription":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Preference for treatment vs AS","type":"Preferred Question Text","description":"Preference for treatment vs AS","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F34F484-1775-77A2-E053-F662850AC643","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeDescription":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}